Literature DB >> 14466931

Studies in liver glycogen disease. Effects of glucagon and other agents on metabolic pattern and clinical status.

C U LOWE, J E SOKAL, L L MOSOVICH, E J SARCIONE, B H DORAY.   

Abstract

Entities:  

Keywords:  GLUCAGON/therapy; GLYCOGENOSIS; LIVER/chemistry; PHOSPHATASES/chemistry; PHOSPHORYLASES/chemistry

Mesh：

Substances：

Year:  1962        PMID： 14466931     DOI： 10.1016/0002-9343(62)90272-3

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

Review 1.  INHERITED ENZYME DEFECTS: A REVIEW.

Authors:  T HARGREAVES
Journal:  J Clin Pathol       Date:  1963-07       Impact factor: 3.411

2.  Ketosis in hepatic glycogenosis.

Authors:  J Fernandes; N A Pikaar
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

3.  Observations on the structure and function of liver in Indian diabetics.

Authors:  H Vaishnava; P D Gulati; V N Damodaran
Journal:  Diabetologia       Date:  1970-02       Impact factor: 10.122

4.  A screening method for liver glycogen diseases.

Authors:  J Fernandes; F Huijing; J H van de Kamer
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

5.  Glycogen storage disease type IV, amylopectinosis.

Authors:  B Levin; E A Burgess; P E Mortimer
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

6.  Value of the glucagon test in screening for hepatic glycogen storage disease.

Authors:  D B Dunger; J V Leonard
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

7.  Glycogenosis type Ib. Further evidence for a membrane disease.

Authors:  J Schaub; K Bartholomé; D Feist; H Schmidt
Journal:  Eur J Pediatr       Date:  1981-02       Impact factor: 3.183

Review 8.  Glycogen storage disease type Ib.

Authors:  J Schaub; K Heyne
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.